Newron Pharmaceuticals Statistics

Total Valuation

SWX:NWRN has a market cap or net worth of CHF 318.74 million. The enterprise value is 327.39 million.

Market Cap	318.74M
Enterprise Value	327.39M

Important Dates

The next confirmed earnings date is Tuesday, September 22, 2026.

Earnings Date	Sep 22, 2026
Ex-Dividend Date	n/a

Share Statistics

SWX:NWRN has 20.81 million shares outstanding. The number of shares has decreased by -2.98% in one year.

Current Share Class	20.81M
Shares Outstanding	20.81M
Shares Change (YoY)	-2.98%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	10.14%
Owned by Institutions (%)	12.78%
Float	18.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.90
PB Ratio	-30.75
P/TBV Ratio	n/a
P/FCF Ratio	10.60
P/OCF Ratio	10.58
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-26.56
EV / Sales	18.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	10.89

Financial Position

The company has a current ratio of 0.76

Current Ratio	0.76
Quick Ratio	0.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	1.18
Interest Coverage	-1.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.65%
Return on Invested Capital (ROIC)	-23.34%
Return on Capital Employed (ROCE)	46.62%
Weighted Average Cost of Capital (WACC)	8.81%
Revenue Per Employee	659,507
Profits Per Employee	-456,510
Employee Count	27
Asset Turnover	0.37
Inventory Turnover	n/a

Taxes

In the past 12 months, SWX:NWRN has paid 823,953 in taxes.

Income Tax	823,953
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +114.87% in the last 52 weeks. The beta is 0.82, so SWX:NWRN's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+114.87%
50-Day Moving Average	16.87
200-Day Moving Average	15.11
Relative Strength Index (RSI)	41.99
Average Volume (20 Days)	67,347

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:NWRN had revenue of CHF 17.81 million and -12.33 million in losses. Loss per share was -0.62.

Revenue	17.81M
Gross Profit	17.81M
Operating Income	-4.37M
Pretax Income	-11.50M
Net Income	-12.33M
EBITDA	-4.35M
EBIT	-4.37M
Loss Per Share	-0.62

Full Income Statement

Balance Sheet

The company has 26.88 million in cash and 35.53 million in debt, giving a net cash position of -8.65 million or -0.42 per share.

Cash & Cash Equivalents	26.88M
Total Debt	35.53M
Net Cash	-8.65M
Net Cash Per Share	-0.42
Equity (Book Value)	-10.37M
Book Value Per Share	-0.52
Working Capital	-11.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 30.12 million and capital expenditures -43,758, giving a free cash flow of 30.07 million.

Operating Cash Flow	30.12M
Capital Expenditures	-43,758
Depreciation & Amortization	19,409
Net Borrowing	-12.74M
Free Cash Flow	30.07M
FCF Per Share	1.45

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -24.56% and -69.22%.

Gross Margin	100.00%
Operating Margin	-24.56%
Pretax Margin	-64.59%
Profit Margin	-69.22%
EBITDA Margin	-24.45%
EBIT Margin	-24.56%
FCF Margin	168.89%

Dividends & Yields

SWX:NWRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.98%
Shareholder Yield	2.98%
Earnings Yield	-3.87%
FCF Yield	9.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:NWRN has an Altman Z-Score of 1.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.66
Piotroski F-Score	2